Researchers Push for Mass Blood Tests as a Covid-19 Strategy
While it might seem wasteful to test the seemingly healthy, tracking antibodies could show how widely the virus has spread—and who may now be immune.
While it might seem wasteful to test the seemingly healthy, tracking antibodies could show how widely the virus has spread—and who may now be immune.
First deny the problem, then say the solution is too expensive? The playbook here is all too familiar.
Manufacturers are producing as many as they can to care for Covid-19 patients with breathing problems. Now the federal government is asking for even more.